BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 7525898)

  • 1. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
    Shin RW; Lee VM; Trojanowski JQ
    J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer disease A68 proteins injected into rat brain induce codeposits of beta-amyloid, ubiquitin, and alpha 1-antichymotrypsin.
    Shin RW; Bramblett GT; Lee VM; Trojanowski JQ
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6825-8. PubMed ID: 8393578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW; Lee VM; Trojanowski JQ
    Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles.
    Tabaton M; Cammarata S; Mancardi G; Manetto V; Autilio-Gambetti L; Perry G; Gambetti P
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2098-102. PubMed ID: 1706517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
    Kondratick CM; Vandré DD
    J Neurochem; 1996 Dec; 67(6):2405-16. PubMed ID: 8931473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
    Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
    Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-tau in Alzheimer's disease.
    Brion JP; Couck AM; Robertson J; Loviny TL; Anderton BH
    J Neurochem; 1993 Apr; 60(4):1372-82. PubMed ID: 7681101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual enhancement of double immunofluorescent signals by CARD: participation of ubiquitin during formation of neurofibrillary tangles.
    Uchihara T; Nakamura A; Nagaoka U; Yamazaki M; Mori O
    Histochem Cell Biol; 2000 Dec; 114(6):447-51. PubMed ID: 11201605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
    Dickson TC; Saunders HL; Vickers JC
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles.
    Spillantini MG; Crowther RA; Goedert M
    Acta Neuropathol; 1996 Jul; 92(1):42-8. PubMed ID: 8811124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease.
    Schmidt ML; DiDario AG; Lee VM; Trojanowski JQ
    FEBS Lett; 1994 May; 344(1):69-73. PubMed ID: 8181568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Casein kinase II alteration precedes tau accumulation in tangle formation.
    Masliah E; Iimoto DS; Mallory M; Albright T; Hansen L; Saitoh T
    Am J Pathol; 1992 Feb; 140(2):263-8. PubMed ID: 1739121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
    Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminum induces tau aggregation in vitro but not in vivo.
    Mizoroki T; Meshitsuka S; Maeda S; Murayama M; Sahara N; Takashima A
    J Alzheimers Dis; 2007 Jul; 11(4):419-27. PubMed ID: 17656819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioglioma with neurofibrillary tangles (NFTs): neoplastic NFTs share antigenic determinants with NFTs of Alzheimer's disease.
    Soffer D; Umansky F; Goldman JE
    Acta Neuropathol; 1995; 89(5):451-3. PubMed ID: 7542425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites.
    Su JH; Cummings BJ; Cotman CW
    Neuroreport; 1994 Nov; 5(17):2358-62. PubMed ID: 7533559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.